Interleukin-8 in progression of ER-positive and ER-negative breast cancer patients

被引:0
|
作者
Todorovic-Rakovic, N. [1 ]
Milovanovic, J. [1 ]
Abu Rabi, Z. [1 ]
机构
[1] Inst Oncol & Radiol Serbia, Dept Expt Oncol, Belgrade, Serbia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
398
引用
收藏
页码:S115 / S115
页数:1
相关论文
共 50 条
  • [1] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    Jordan, VC
    [J]. BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S4 - S4
  • [2] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    VC Jordan
    [J]. Breast Cancer Research, 7
  • [3] AgNOR analysis of ER-positive and ER-negative cells in breast cancer.
    Guski, H
    Winzer, KJ
    Hufnagl, P
    Gunther, L
    [J]. EUROPEAN JOURNAL OF HISTOCHEMISTRY, 1996, 40 (04): : 341 - 341
  • [4] AgNOR analysis of ER-positive and ER-negative tumor cells in breast cancer
    Guski, E
    Winzer, KJ
    Hufnagl, P
    Günther, L
    Kaufmann, O
    [J]. PROCEEDINGS OF THE GERMAN SOCIETY FOR PATHOLOGY 82ND MEETING - 1998: SOFT TISSUE TUMORS, 1998, : 470 - 470
  • [5] Oxysterol signalling is retained in ER-negative and supressed in ER-positive breast cancer
    Hutchinson, Samantha
    Battaglia, Sebastiano
    Roberg-Larsen, Hanne
    Lianto, Priscilia
    Hughes, Thomas
    Thorne, James
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 2020, 79 (OCE2) : E142 - E142
  • [6] Cell signaling events differentiate ER-negative subtypes from ER-positive breast cancer
    Maria J. Worsham
    Dhanajay Chitale
    Kang Mei Chen
    Indrani Datta
    George Divine
    [J]. Medical Oncology, 2015, 32
  • [7] Cell signaling events differentiate ER-negative subtypes from ER-positive breast cancer
    Worsham, Maria J.
    Chitale, Dhanajay
    Chen, Kang Mei
    Datta, Indrani
    Divine, George
    [J]. MEDICAL ONCOLOGY, 2015, 32 (05)
  • [8] Different proliferation patterns in breast cancer:: AgNOR measurements in ER-negative and ER-positive tumor cells
    Günther, L
    Hufnagl, P
    Winzer, KJ
    Guski, H
    [J]. ANALYTICAL CELLULAR PATHOLOGY, 2000, 20 (04): : 155 - 162
  • [9] Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers
    Liu, Dingxie
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 183 (01) : 95 - 105
  • [10] Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers
    Dingxie Liu
    [J]. Breast Cancer Research and Treatment, 2020, 183 : 95 - 105